QA: Evelo Biosciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001694665_2023_Evelo_Biosciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001694665, Evelo Biosciences Inc

  xvar xval
0 AssetsCurrent 51,573,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,842,000
3 remainder_Assets 8,026,000
4 LiabilitiesCurrent 12,395,000
5 LiabilitiesNoncurrent 57,038,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,518,979
9 ResearchAndDevelopmentExpense 76,141,447
10 remainder_Expenses 3,432,130
11 remainder_Revenues 0
12 remainder_NetIncome -5,301,388
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 64,441,000
1 Liabilities 69,433,000
2 Expenses 109,092,556
3 Revenues 0
4 StockholdersEquity -4,992,000
5 NetIncome -114,393,944
6 ComprehensiveNetIncome -114,393,944
7 BaseVar 124,133,972
8 EconomicCapitalRatiobeforeLimitedLiability -1.87
9 EconomicCapitalRatio 1.07

Edgar->Model Mapping

Feature Distribution

Change over Time